Loading insider details...
Latest Form 4 (Aug 17, 2026): Grant/Award of 100,000 EWTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 100,000 | n/a |
| Aug 14, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,781 | n/a |
| May 7, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,209 | n/a |
| Feb 7, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 10,000 | $19.3K |
| Sep 24, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 42,068 | $81.2K |
| Aug 14, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 138,750 | n/a |
| May 3, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,208 | n/a |
| Feb 9, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 600 | $1.2K |
| Aug 18, 2023 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 220,000 | n/a |
| May 3, 2023 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,208 | n/a |